ТЕРАПИЯ ЦИКЛОСПОРИНОМ А ДЕТЕЙ С ФОКАЛЬНО-СЕГМЕНТАРНЫМ ГЛОМЕРУЛОСКЛЕРОЗОМ
Аннотация
Ключевые слова: дети, фокально-сегментарный гломерулосклероз, циклоспорин, метилпреднизолон.
(Вопросы современной педиатрии. 2009; 8(5):93-97)
Об авторах
О.В. КомароваРоссия
А.Н. Цыгин
Россия
Л.В. Леонова
Россия
А.Г. Кучеренко
Россия
О.А. Зробок
Россия
Т.В. Вашурина
Россия
М.В. Рожкова
Россия
Список литературы
1. Haas M., Meehan S.M., Karrison T.G., Spargo B.H. Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976–1979 and 1995–1997. Am. J. Kidney Dis. 1997; 30 (5): 621–631.
2. Braden G.L., Mulhern J.G., O'Shea M.H. et al. Changing incidence of glomerular diseases in adults. Am. J. Kidney Dis. 2000; 35 (5): 878–883.
3. Ichikawa I., Fogo A. Focal segmental glomerulosclerosis. Pediatr. Nephrol. 2004; 10 (1): 347–391.
4. Korbet S.M. Treatment of primary focal segmental glomerulosclerosis. J. Am. Soc. Nephrol. 2002; 62: 2301–2310.
5. Lieberman K.V., Tejani A.A. randomized double blind placebo controlled trial of cyclosporine in steroid-resistant focal segmental glomerulosclerosis in children. J. Am. Soc. Nephrol. 1996; 7 (1): 56–63.
6. Tsygin A., Sergeeva T., Voznesenskaya T. et al. Growing incidense of focal and segmental glomerulosclerosis as a cause of steroid resistent nephrotic syndrome in Russian children. Paediatric clinical nephrology, acute and chronic renal failure (Abstract E2). 2004. P. 259.
7. Rydel J.J., Korbet S.M., Borok R.Z., Schwartz M.M. Focal segmental glomerular sclerosis in adults: presentation, course, and response to treatment. Am. J. Kidney Dis. 1995; 25 (4): 534–542.
8. Tune B.M., Mendoza S.A. Treatment of the idiopathic nephrotic syndrome: regimens and outcomes in children and adults. J. Am. Soc. Nephrol. 2001; 12: 44–47.
9. Цыгин А.Н., Комарова О.В., Сергеева Т.В. и др. Нефротический синдром. Клинические рекомендации по педиатрии. Под ред. А.А. Баранова. М.: Гэотар-Медиа. 2005. C. 107–128.
10. Suthanthiran M., Strom T.B. Immunoregulatory drugs: mechanistic basis for use in organ transplantation. Pediatr. Nephrol. 1997; 11 (5): 651–657.
11. Scheinman R.I., Cogswell P.G., Lofquist A.K., Baldwin A.S. Role of transcription activation of Iβα in mediation of immunosupression by glucocorticoids. Sience. 1995; 270: 283–286.
12. Meyrier A., Simon P., Perret G., Condamin-Meyrier M.C. Remission of idiopathic nephrotic syndrome after treatment with cyclosporine. Br. Med. J. 1986; 292 (6523): 789–792.
13. Tejani A., Butt K., Trachtman H. et al. Cyclosporine A induced remission of relapsing nephrotic syndrome in children. Kidney Int. 1988; 33: 729–734.
14. Klein M., Radhakrishnan J., Appel G. Cyclosporine treatment of glomerular diseases. Ann. Rev. Med. 1999; 50: 1–15.
15. Kveder R. Therapy-resistant focal and segmental glomerulosclerosis. Nephrol. Dial. Transplant. 2003; 18: 34–37.
16. Korbet S.M., Schwartz M.M., Lewis E.J. Primary focal segmental glomerulosclerosis: clinical course and response to therapy. Am. J. Kidney Dis. 1994; 23 (6): 773–783.
17. Korbet S.M. Angiotensin antagonists and steroids in the treatment of focal segmental glomerulosclerosis. Semin. Nephrol. 2003; 23 (2): 219–228.
18. Niaudet P., for the French Society of Pediatric Nephrology. Treatment of childhood steroid resistant idiopathic nephrosis with a combination of cyclosporine and prednisone. J. Pediatr. 1994; 125 (5): 981–986.
19. Waldo F.B., Benfield M.R., Kohaut E.C. Therapy of focal and segmental glomerulosclerosis with methylprednisolone, cyclosporine A, and prednisone. Pediatr. Nephrol. 2009; 12 (5): 397–400.
20. Cattran D.C., Appel G.B., Hebert L.A. et al. A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. Kidney Int. 1999; 56 (6): 2220–2226.
21. Ponticelli C., Rizzoni G., Edefonti A. et al. A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome. Kidney Int. 1993; 43 (6): 1377–1384.
22. Burgess E. Management of focal segmental glomerulosclerosis: evidence-based recommendations. Kidney Int. Suppl. 1999; 70: 26–32.
23. El-Husseini A., El-Basuony F., Mahmoud I. et al. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single centre experience. Nephrol. Dial. Transplant. 2005; 20 (11): 2433–2438.
24. Meyrier A., Noel L.H., Auriche P., Callard P. Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome. Collaborative Group of the Societe de Nephrologie. Kidney Int. 1994; 45 (5): 1446–1456.
25. Ehrich J.H., Geerlings C., Zivicnjak M. et al. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated. Nephrol. Dial. Transplant. 2007; 22 (8): 2183-2193.
26. Sümegi V., Haszon I., Bereczki C. et al. Long term follow up after cyclophosphamide and cyclosporine-A therapy in steroid dependent and resistant nephrotic syndrome. Pediatr. Nephrol. 2008; 23 (7): 1085–1092.
Рецензия
Для цитирования:
Комарова О., Цыгин А., Леонова Л., Кучеренко А., Зробок О., Вашурина Т., Рожкова М. ТЕРАПИЯ ЦИКЛОСПОРИНОМ А ДЕТЕЙ С ФОКАЛЬНО-СЕГМЕНТАРНЫМ ГЛОМЕРУЛОСКЛЕРОЗОМ. Вопросы современной педиатрии. 2009;8(5):93-97.
For citation:
Komarova O., Tsygin A., Leonova L., Kucherenko A., Zrobok O., Vashurina T., Rozhkova M. TREATMENT OF CHILDREN WITH FOCAL SEGMENTAL GLOMERULAR SCLEROSIS WITH CYCLOSPORINE A. Current Pediatrics. 2009;8(5):93-97.